Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit is the smaller component of the prokaryotic 70S ribosome, consisting of a 16S ribosomal RNA (rRNA) molecule and approximately 21 ribosomal proteins [1, 5]. Its primary biological function is to initiate translation and ensure the accuracy of protein synthesis by decoding the messenger RNA (mRNA) sequence [1, 12]. The decoding center, located within the 16S rRNA, facilitates the correct pairing between mRNA codons and transfer RNA (tRNA) anticodons by monitoring the geometry of the codon-anticodon helix [9, 12]. This subunit is a major therapeutic target for several classes of antibiotics, including aminoglycosides, tetracyclines, and spectinomycin, which are used to treat a wide range of bacterial infections [2, 13]. Aminoglycosides, such as streptomycin and gentamicin, bind specifically to the 16S rRNA A-site and ribosomal protein S12, inducing conformational changes that lead to mRNA misreading and the production of non-functional proteins [2, 7, 11]. Resistance to these drugs often arises through mutations in the 16S rRNA or protein S12, or through the action of 16S rRNA methyltransferases that block drug binding [4, 15].
Drugs targeting the 30S subunit primarily inhibit bacterial protein synthesis through several distinct mechanisms. Aminoglycosides bind to the 16S rRNA decoding center (A-site) and ribosomal protein S12, inducing a conformational change that stabilizes the flipped-out state of conserved nucleotides A1492 and A1493; this leads to the acceptance of near-cognate tRNAs, resulting in mRNA misreading (mistranslation) and the production of aberrant proteins [2, 11, 12]. Aminoglycosides also inhibit the translocation of the mRNA-tRNA complex [6, 14]. Tetracyclines bind to the 30S subunit to sterically block the attachment of aminoacyl-tRNA to the A-site, thereby preventing peptide chain elongation [5, 12]. Spectinomycin binds to the 30S subunit and specifically inhibits the translocation step [1, 15].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit (30S subunit) (30S subunit).